Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Iridium Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel water-based synthesis improves purity and yield for metolachlor production. Reduces costs and enhances supply chain reliability for global buyers.
Discover advanced iridium-catalyzed synthesis for chiral bisallyl compounds with three consecutive chiral centers. Enhance supply chain reliability and reduce manufacturing costs.
Patent CN117362359A reveals record-breaking asymmetric hydrogenation technology. Achieve superior purity and cost efficiency in pharmaceutical intermediate manufacturing.
One-step synthesis patent analysis for high-purity iridium catalysts reducing cost and lead time for pharmaceutical intermediates manufacturing and ensuring supply chain reliability.
Patent CN112279743B details a novel iridium-catalyzed asymmetric hydrogenation method for chiral alpha-amino acid esters, offering high enantioselectivity and industrial scalability for pharmaceutical intermediates.
Patent CN110002952B reveals efficient iridium catalysis for alpha,beta-unsaturated alcohols, offering cost-effective pharma intermediate synthesis.
Patent CN113195460A details enantioselective iridium-catalyzed hydrogenation of oximes. This breakthrough offers cost reduction in agrochemical intermediate manufacturing and reliable supply chain solutions.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.